In-Vitro Toxicology Testing Market – Trends Forecast Till 2030

1
In-Vitro Toxicology Testing Market Trends, Size,
Share, Demands, Overview, Growth, Revenue and
Forecast to 2030
sales_at_delvens.com www.delvens.com
2
In-Vitro Toxicology Testing Market - Trends
Forecast Till 2030
In-Vitro Toxicology Testing Market Size, Share
Trends Analysis Report By Technology (Cell
Culture, High Throughput), By Method, By
Application, By End-use (Diagnostics, Chemical
Industry, Food Industry) and region (North
America, Europe, Asia-Pacific, Middle East and
Africa and South America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/in-vitro-t
oxicology-testing-market-trends-forecast-till-2030
sales_at_delvens.com
www.delvens.com
3
Market Overview
The global In Vitro Toxicology Testing Market
size is projected to reach a CAGR of 10.8 from
2023-2030. In vitro is the process that helps
examine harmful chemicals over the isolated part
of the organism. It is used to identify hazardous
chemical substances and helps detect toxicity at
the early stages of the development of new
products, such as drugs, cosmetics, and food
additives. In vitro, toxicity testing (IVTT) is
mainly used for safety evaluation in drug
development and also for ranking the chemicals
according to their potency. The absorption,
distribution, metabolism, excretion (ADME),
dose-response, and threshold response of the drug
can also be determined by in vitro toxicity
testing. The rise in the number of RD procedures
will act as a major driver accelerating the
in-vitro toxicology testing markets growth rate.
Another significant factor resulting in the
expansion of the market is the growing
development of 3D cell culture. Furthermore, a
ban on animal testing and rising environmental
concerns are the major drivers that will enhance
the growth of the market.
sales_at_delvens.com
www.delvens.com
4
Market Overview
Likewise, a rise the government funding for
research along with favourable reimbursement
policies for developing automated and technically
advanced equipment for laboratory analysis will
show a positive impact on the markets growth
rate. Growing healthcare expenditure, rapid
urbanization, and a rise in the level of
disposable incomes in developing and developed
countries will influence the growth rate of the
in-vitro toxicology testing market. On the other
hand, the rising number of toxicology databases
and advancements in medical technology will
provide beneficial opportunities for the in-vitro
toxicology testing market growth. Adding to this
high cost associated with testing and the
scarcity of in vitro models to study complex
endpoints are factors that will obstruct market
growth.
sales_at_delvens.com
www.delvens.com
5
Market Segmentation

• In Vitro, Toxicology Testing Market is segmented
  into various segments such as technology,
  application, method, end-use, and region
• On the basis of technology
• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology
• On the basis of the application
• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Ocular Toxicity

sales_at_delvens.com
www.delvens.com
6
Market Segmentation

• On the basis of the method
• Cellular assay
• Biochemical Assay
• In-Silico
• Ex-vivo
• On the basis of end use
• Pharmaceutical Industry
• Cosmetics Household Products
• Academic Institutes and Research Laboratories
• Diagnostics
• Chemical Industry
• Food Industry

sales_at_delvens.com
www.delvens.com
7
Competitive Landscape
Thermo Fisher Scientific Agilent
Technologies Bio-Rad Laboratories Danaher
Corporation Quest Diagnostics Merck KGaA Perkin
Elmer, Inc. Laboratory Corporation of America
Holdings Eurofins Scientific Charles River
Laboratories International, Inc. Abbott
Inquire Before Buying https//www.delvens.com/In
quire-before-buying/in-vitro-toxicology-testing-ma
rket-trends-forecast-till-2030
sales_at_delvens.com
www.delvens.com
8
Recent Developments
In March 2022, Laboratory Corporation of America
Holdings acquired AtlantiCare diagnostic clinical
laboratory services. In September 2021,
Laboratory Corporation of America Holdings
Acquired Myriad Autoimmunes Vectra Testing
Business, an autoimmune business unit, including
the Vectra rheumatoid arthritis (RA) assay.
Purchase This Report https//www.delvens.com/chec
kout/in-vitro-toxicology-testing-market-trends-for
ecast-till-2030
sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-8638-5055 sales_at_d
elvens.com WEBSITE https//delvens.com/
sales_at_delvens.com
www.delvens.com